NCT06213948View on ClinicalTrials.gov

Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators

PHASE1RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Functional Disorder of StomachHealthy
Interventions
DRUG

Mirtazapine 15 MG

"Mirtazapine~* Commercial name: Remeron® SolTab~* Pharmaceutical form: film-coated tablets (15 mg)"

Trial Locations (1)

16150

RECRUITING

Hospital Universiti Sains Malaysia, Kota Bharu

All Listed Sponsors
collaborator

Ministry of Higher Education, Malaysia

OTHER

lead

Universiti Sains Malaysia

OTHER